Protein Chaperones and Protection from Neurodegenerative Diseases |
|
| Editor:
| Witt, Stephan N. |
| Series edited by:
| Uversky, Vladimir |
| Series title: | Wiley Series in Protein and Peptide Science Ser. |
| ISBN: | 978-1-118-35358-5 |
| Publication Date: | Apr 2012 |
| Publisher: | John Wiley & Sons, Incorporated
|
| Book Format: | Digital download |
| List Price: | Contact Supplier contact
Contact Supplier contact
|
Book Description:
|
How protein chaperones protect cells from neurodegenerative diseases
Including contributions from leading experts, Protein Chaperones and Protection from Neurodegenerative Diseases provides an in-depth exploration of how protein chaperones are involved in shielding cells from toxic aggregated or misfolded protein states that cause ALS, Parkinson's, and related diseases.
Examining how different protein chaperones ameliorate the toxicity of proteins that are known to...
More Description
How protein chaperones protect cells from neurodegenerative diseases
Including contributions from leading experts, Protein Chaperones and Protection from Neurodegenerative Diseases provides an in-depth exploration of how protein chaperones are involved in shielding cells from toxic aggregated or misfolded protein states that cause ALS, Parkinson's, and related diseases.
Examining how different protein chaperones ameliorate the toxicity of proteins that are known to cause neurodegenerative damage, the book addresses both research and clinical perspectives on chaperone and anti-chaperone properties. The intersection of molecular chaperones and neurodegeneration is an intensely studied area, partly because of the potential for manipulating the expression of molecular chaperones to thwart the progression of debilitating diseases, and partly because of the ever-aging global population.
Discussing the potential to harness the power of protein chaperones, and future directions for research, discovery, and therapeutics, this book is essential reading for scientists working in the fields of biochemistry, molecular medicine, pharmacology and drug discovery, biotechnology and pharmaceutical companies, advanced students, and anyone interested in this cutting-edge topic.